Though the FDA has requested no new data, the additional information reflects a major amendment to Rhythm’s supplemental new drug application (sNDA), allowing the FDA more time to go over the ...

Approval of J&J's Darzalex marks a milestone for high-risk sMM patients, but GlobalData analyst Biswajit Podder believes ...

Eli Lilly and Novo Nordisk have agreed pricing deals for GLP-1RA brands, a pivotal moment in the obesity treatment market.

Abzena and Mabqi have announced a partnership integrating antibody discovery capabilities with development and manufacturing ...

Alvotech and Advanz Pharma have announced the receipt of marketing authorisations from the MHRA for all four formulations of ...